Wegovy savings card: from $149 a month without insurance

How to pay the least

Lowest posted price

from $149 a month

Wegovy from Novo Nordisk, without insurance.

No generic is sold yet.

Compare every option

Brand nameWegovy

Authorized genericsemaglutide

Regular genericsemaglutide

What you’d pay

From$149a month with the maker’s card

Not soldThere isn’t one

Not soldNone sold yet

Same as Wegovy?

The original

–

Coverage: Medicare and many other plans cover weight-loss drugs only in some cases. Ask your plan.

Brand nameThe maker’s card

Wegovy Savings Offer

Savings card from Novo Nordisk

No insurance · from $149 a month

Insurance · as little as $25 a month

The card takes up to $100 a month off your co-pay.

Or text SAVE to 83757. See the offer on wegovy.com

In the maker’s words

“Pay as little as $25, subject to a maximum savings of $100/month.”

“Patients pay $149 for each month of 1.5 mg, and $199 per month for 4 mg and $299 per month for 9 mg and 25 mg.”

From the maker’s offer on wegovy.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Brand nameTrumpRx.gov price

TrumpRx.gov, the federal government’s drug price site, lists Wegovy at a price its maker agreed to, for people paying without insurance.

Wegovy Pill $149for 30 tablets, for the first 1 fills, then $1491.5 mgGet the free coupon on TrumpRx’s page and show it at the pharmacy.
TrumpRx’s terms
“Self-pay pricing varies by dose. Eligibility and restrictions apply. Government beneficiaries excluded. One month is defined as one bottle containing 30 tablets. Novo Nordisk reserves the right to modify or cancel this offer at any time. See full Terms and Conditions.”
Wegovy Pen $199for the first 2 fills, then $349Prefilled Pen, 0.25/0.5 mg/mLGet the free coupon on TrumpRx’s page and show it at the pharmacy.
TrumpRx’s terms
“Limited Time Offer – New patients pay $199* for the first two monthly fills of Wegovy® (semaglutide) injection 0.25mg and 0.5mg, then $349/month. Only available for 2 monthly fills between 11/17/2025- 12/31/2026. For each fill after, pay $349/month for Wegovy® 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg and $399/month for Wegovy® HD 7.2mg.”

From TrumpRx.gov, read October 28, 2026. Its page opens on this price; other strengths and amounts are priced there too. With insurance, check your co-pay first: it may be lower.

Authorized genericNot sold

There isn’t one. An authorized generic is Wegovy itself, from the same company, sold without the brand name, and usually for less. For now Wegovy is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist.

WEGOVY injection is indicated in combination with a reduced calorie diet and increased physical activity:

to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight.
to reduce excess body weight and maintain weight reduction long term in:
oadults and pediatric patients aged 12 years and older with obesity.
oadults with overweight in the presence of at least one weight-related comorbid condition.
for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults. This indication is approved under accelerated approval based on improvement of MASH and fibrosis. Continued approval for this indication may be contingent upon the verification and description of clinical benefit in a confirmatory trial.

WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity:

to reduce the risk of major adverse CV events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight.
to reduce excess body weight and maintain weight reduction long term in adults with obesity, or in adults with overweight in the presence of at least one weight-related comorbid condition.

Limitations of Use:

Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.

Source: the FDA label for Wegovy (Novo Nordisk Pharmaceutical Industries, LP), June 18, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/wegovy/